Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 39.88 Million | 8.25 Million | - | 37.78 Million | - |
| Cost of Revenue | 98.93 Million | 5.82 Million | 59.23 Million | - | 45.94 Million |
| Gross Profit | -59.04 Million | 2.43 Million | -59.23 Million | 37.78 Million | -45.94 Million |
| Operating Expenses | 1.33 Billion | 2.04 Billion | 2.58 Billion | 2.52 Billion | 3.28 Billion |
| Selling, General and Administrative Expenses | 633 Million | 601.29 Million | 603.9 Million | 606.27 Million | 532.07 Million |
| Research and Development Expenses | 788.78 Million | 1.51 Billion | 2.04 Billion | 1.97 Billion | 2.75 Billion |
| Other Expenses | - | 15.21 Million | -24.81 Million | -4.77 Million | -10.13 Million |
| Cost and Expenses | 1.43 Billion | 2.04 Billion | 2.58 Billion | 2.52 Billion | 3.28 Billion |
| Operating Income | -1.39 Billion | 2.03 Billion | 2.58 Billion | -2.48 Billion | -3.28 Billion |
| Interest Expense | - | 11.56 Million | 18.16 Million | 16.4 Million | 24.81 Million |
| Income Tax Expense | - | -4.04 Billion | -5.18 Billion | 63.02 Million | -39.67 Million |
| Earnings before Tax | -1.48 Billion | -2.01 Billion | -2.61 Billion | -2.43 Billion | -3.1 Billion |
| Net Income | -1.48 Billion | -2.01 Billion | -2.61 Billion | -2.43 Billion | -3.06 Billion |
| Earnings Per Share Basic | -26.79 | -40.92 | -57.46 | -56.90 | -71.57 |
| Earnings Per Share Diluted | -26.79 | -40.92 | -57.46 | -56.90 | -71.57 |
| Weighted Average Shares Outstanding | 55.59 Million | 49.26 Million | 45.53 Million | 42.83 Million | 42.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.59 Million | 49.26 Million | 45.53 Million | 42.83 Million | 42.83 Million |
| Gross Margin | -1.48 | 0.29 | - | 1.00 | - |
| EBIT Margin | -34.93 | -235.69 | - | -62.87 | - |
| Profit Margin | -37.35 | -244.23 | - | -64.51 | - |
| EBITDA | -1.39 Billion | -1.94 Billion | -2.53 Billion | -2.37 Billion | -3.03 Billion |
| Earnings Before Tax Margin | -34.94 | 246.91 | - | -65.74 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.74 Million | 5.03 Million | 9.32 Million | 39.88 Million | 13.33 Million | 12.05 Million |
| Cost of Revenue | 18.16 Million | 1.04 Million | 25.69 Million | 98.93 Million | 3.43 Million | 4.1 Million |
| Gross Profit | -13.41 Million | 3.99 Million | -16.37 Million | -59.04 Million | 9.9 Million | 7.94 Million |
| Operating Expenses | 324.36 Million | 341.4 Million | 346.6 Million | 1.33 Billion | 293.15 Million | 309.87 Million |
| Selling, General and Administrative Expenses | 183.96 Million | 176.73 Million | 141.46 Million | - | 147.15 Million | 148.93 Million |
| Research and Development Expenses | 140.39 Million | 164.67 Million | 205.13 Million | - | 145.99 Million | 160.93 Million |
| Other Expenses | 11.59 Million | -5.64 Million | - | - | -37 Thousand | 1.11 Million |
| Cost and Expenses | 342.53 Million | 342.45 Million | 372.29 Million | 1.43 Billion | 296.58 Million | 313.97 Million |
| Operating Income | -337.78 Million | -337.41 Million | -362.97 Million | -1.39 Billion | -283.25 Million | -301.92 Million |
| Interest Expense | 2 Million | 2.08 Million | 2.17 Million | - | 2.39 Million | 2.43 Million |
| Income Tax Expense | - | -3.24 Million | - | - | 3.25 Million | 3.99 Million |
| Earnings before Tax | -326.19 Million | -342.74 Million | -462.51 Million | -1.48 Billion | -282.39 Million | -300.35 Million |
| Net Income | -326.19 Million | -342.74 Million | -462.51 Million | -1.48 Billion | -282.39 Million | -300.35 Million |
| Earnings Per Share Basic | -5.79 | -6.10 | -8.25 | - | -5.06 | -5.41 |
| Earnings Per Share Diluted | -5.79 | -6.10 | -8.25 | - | -5.06 | -5.41 |
| Weighted Average Shares Outstanding | 56.29 Million | 56.15 Million | 56.06 Million | 55.59 Million | 55.8 Million | 55.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.29 Million | 56.15 Million | 56.06 Million | 55.59 Million | 55.8 Million | 55.56 Million |
| Gross Margin | -2.83 | 0.79 | -1.76 | -1.48 | 0.74 | 0.66 |
| EBIT Margin | -67.52 | -64.74 | -36.43 | - | -19.34 | -22.83 |
| Profit Margin | -68.69 | -68.06 | -49.63 | -37.35 | -21.18 | -24.92 |
| EBITDA | -320.67 Million | -326.05 Million | -339.48 Million | - | -257.92 Million | -275.2 Million |
| Earnings Before Tax Margin | -71.13 | -67.00 | -38.95 | -34.94 | -21.24 | -25.05 |
PNA1V
MAIRE
IIFLSEC
CRPG5
8065
2195